W

This chapter presents information on neonatal drugs that begin with W, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Warfarin, and Whooping cough vaccine (including tetanus and diphtheria)

V

This chapter presents information on neonatal drugs that begin with V, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Vancomycin, Varicella-zoster immunoglobulin and vaccine, Vasopressin, desmopressin, and terlipressin, Vigabatrin, Vitamin A (retinol), Vitamin B12 (hydroxocobalamin), Vitamin D (special formulations), Vitamin D (standard formulations), Vitamin E (alpha tocopherol), Vitamin K1 = phytomenadione (rINN), phytonadione (USAP), and Vitamins (multi-vitamins)

S

This chapter presents information on neonatal drugs that begin with S, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Salbutamol = Albuterol (USAN), Sildenafil, Skin care and skin sterility, Sodium phenylbutyrate and glycerol phenylbutyrate, Sodium benzoate, Sodium bicarbonate, Sodium chloride, Sodium fusidate (fusidic acid), Sodium valproate, Sotalol, Spiramycin, Spironolactone, Stiripentol, Streptokinase, Sucrose, Sulfadiazine = Sulphadiazine (former BAN), Surfactants, and Suxamethonium = Succinylcholine (USAN)

R

This chapter presents information on neonatal drugs that begin with R, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Radiological contrast media, Raltegravir, Ranitidine, Recombinant human granulocyte colony-stimulating factors (rhG-CSF), Remifentanil, Rhesus (D) immunoglobulin, Ribavirin = Tribavirin (former BAN), Rifampicin = Rifampin (USAN), Rocuronium, Rotavirus vaccines, and Rubella vaccine

E

This chapter presents information on neonatal drugs that begin with E, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Enemas, laxatives, and suppositories, Enoxaparin, Enzyme replacement therapy, Epoetin (recombinant human erythropoietin = rEPO), Epoprostenol and other prostanoids (iloprost and teoprostinil), Erythromycin, Esomeprazole, Ethambutol, and Eye drops (and ointments)

U

This chapter presents information on neonatal drugs that begin with U, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Ubidecarenone (coenzyme Q10), Urokinase, and Ursodeoxycholic acid = Ursodiol (USAN)

Q

This chapter presents information on neonatal drugs that begin with Q, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Quinine

M

This chapter presents information on neonatal drugs that begin with M, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Magnesium sulfate (Magnesium sulphate = former BAN), Mebendazole, Mefloquine, Melatonin, Meningococcal vaccines, Mercaptamine (Cysteamine— former BAN), Meropenem, Methadone, Methyldopa, Methylthioninium chloride (Methylene blue = former BAN), Metoclopramide, Metronidazole, Micafungin, Miconazole, Midazolam, Formula milk thickeners and anti-reflux milks, Milrinone, Misoprostol, Mivacurium, Morphine, and Mupirocin

K

This chapter presents information on neonatal drugs that begin with K, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Ketamine

H

This chapter presents information on neonatal drugs that begin with H, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Haemophilus influenzae type b (Hib) vaccine, Heparin, Hepatitis B vaccine, Hyaluronidase, Hydralazine, and Hydrocortisone